We further performed the experiment using DC101, a VEGFR2 neutralizing antibody, to see whether antibody‐mediated VEGFR2 blockade can reduce the PTU‐induced angiofollicular remodeling as well as goiter weights. The gene discussed is KDR; the disease is goiter.